GlassScriptPhysician profile
Dean R Goodless
NPI 1932120326
$5,694.48
in general payments reported to CMS, 2019-2025
36 companies · $1,157 in 2025
The $1,157 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,156 · 2020: $944 · 2021: $740 · 2022: $571 · 2023: $647 · 2024: $479 · 2025: $1,157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,183 · Education: $99.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,183.33 |
| Education | $99.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,149.79 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $812.28 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $458.82 | 2019-2025 | Dupixent |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $378.96 | 2019-2025 | Siliq, Jublia, Cabtreo |
| Genzyme Corporation | $360.59 | 2019-2025 | |
| Janssen Biotech, INC. | $294.97 | 2019-2025 | Tremfya |
| Ucb, INC. | $284.41 | 2021-2025 | Bimzelx |
| Incyte Corporation | $229.97 | 2021-2025 | Opzelura |
| Lilly USA, LLC | $223.79 | 2019-2024 | Taltz |
| Sun Pharmaceutical Industries INC. | $206.33 | 2020-2025 | Winlevi, Absorica Ld, Ilumya |
| Pfizer INC. | $142.37 | 2019-2025 | |
| Galderma Laboratories, L.P. | $119.20 | 2021-2025 | Nemluvio |
| Leo Pharma INC. | $111.07 | 2019-2024 | Adbry |
| Arcutis Biotherapeutics, INC. | $91.94 | 2024-2025 | Zoryve |
| Amgen INC. | $87.72 | 2020-2025 | Otezla |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $79.08 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $70.04 | 2023-2025 | Sotyktu |
| Sensus Healthcare, INC. | $57.07 | 2021 | |
| Vyne Pharmaceuticals INC. | $56.56 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $55.21 | 2021-2022 | |
| Genentech USA, INC. | $52.82 | 2019-2021 | |
| Celgene Corporation | $49.98 | 2019 | |
| Journey Medical Corporation | $47.31 | 2024-2025 | |
| Botanix Sb INC | $44.32 | 2025 | Sofdra |
| Sanofi-Aventis U.S. LLC | $32.10 | 2019-2020 | |
| Organon LLC | $23.64 | 2025 | Vtama |
| Dermavant Sciences, INC. | $23.36 | 2024 | Vtama |
| Dusa Pharmaceuticals, INC. | $22.75 | 2019 | |
| Sandoz INC. | $19.46 | 2019 | |
| Lnhc, INC | $18.80 | 2025 | Zelsuvmi |
| Almirall LLC | $17.23 | 2019 | |
| Dermira, INC. | $16.14 | 2020 | |
| Glenmark Therapeutics INC. | $16.00 | 2019 | |
| Sebela Pharmaceuticals INC. | $14.93 | 2019 | |
| Prugen, INC. Pharmaceuticals | $13.86 | 2019 | |
| Strata Skin Sciences, INC. | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Goodless listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.